Blood test may forecast biliary atresia prognosis

NCT ID NCT05848310

Recruiting now Knowledge-focused Sponsor: Children's Hospital of Fudan University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is looking at whether a substance called FGF19 in the blood, measured before surgery, can help predict how well children with biliary atresia will do after their operation. Researchers will follow 200 children for one year after surgery, checking liver function and whether they still have their native liver. The goal is to see if FGF19 levels can be a useful tool for doctors to plan better treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors predict which children with biliary atresia will have better outcomes after surgery, guiding more personalized care.
What could go wrong: This is an observational study, not a treatment trial. It may not find a clear link between FGF19 levels and prognosis, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BILIARY ATRESIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

biliary atresia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BILIARY ATRESIA PROGNOSIS

Contacts and locations

Locations

Children's Hospital of Fudan University
RECRUITING

Shanghai, Shanghai Municipality, 201100, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.